Amarin Corp Plc (AMRN)

[couldbebetter]

Vascepa was initially underpriced as it had to compete against generic
Lovaza. So now the medication is being priced closer to what it should
have been to begin with. In Europe, the price for Vascepa will be
negotiated on a country by country basis, and they do take into
consideration how effective the drug is. I am not concerned about
how Vascepa is priced today, I'm hoping it will be Big Pharma's
problem soon enough.